Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (16)

2024

  1. Natural History of Dilated Cardiomyopathy Due to c.77T>C (p.Val26Ala) in Emerin Protein

    Journal of Clinical Medicine, Vol. 13, Núm. 3

2023

  1. Effects of MIdazolam versus MOrphine in acute cardiogenic pulmonary edema and chronic obstructive pulmonary disease: An analysis of MIMO trial

    American Journal of Emergency Medicine, Vol. 73, pp. 176-181

  2. Effects of midazolam vs morphine in patients with acute pulmonary edema with left ventricular systolic dysfunction: a secondary analysis of data from the MIMO trial

    Emergencias, Vol. 35, Núm. 1, pp. 25-30

  3. Midazolam versus morphine in acute cardiogenic pulmonary edema patients with and without atrial fibrillation: findings from the MIMO trial

    European journal of emergency medicine : official journal of the European Society for Emergency Medicine, Vol. 30, Núm. 2, pp. 78-84

  4. Rationale and Design of the Impact of Air Pollution Due to DESERT Dust in Patients with HEART Failure (DESERT HEART)

    Journal of Clinical Medicine, Vol. 12, Núm. 15

2022

  1. Midazolam versus morphine in acute cardiogenic pulmonary oedema: results of a multicentre, open-label, randomized controlled trial

    European Journal of Heart Failure, Vol. 24, Núm. 10, pp. 1953-1962

  2. The Molecular Weaponry Produced by the Bacterium Hafnia alvei in Foods

    Molecules (Basel, Switzerland), Vol. 27, Núm. 17

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403

2020

  1. ALS-derived fibroblasts exhibit reduced proliferation rate, cytoplasmic TDP-43 aggregation and a higher susceptibility to DNA damage

    Journal of Neurology, Vol. 267, Núm. 5, pp. 1291-1299

  2. GRK2-dependent HuR phosphorylation regulates HIF1α activation under hypoxia or adrenergic stress

    Cancers, Vol. 12, Núm. 5

  3. The Value of Mouse Models of Rare Diseases: A Spanish Experience

    Frontiers in Genetics, Vol. 11

2010

  1. The dopamine transporter is differentially regulated after dopaminergic lesion

    Neurobiology of Disease, Vol. 40, Núm. 3, pp. 518-530

2009

  1. Aging effects on the dopamine transporter expression and compensatory mechanisms

    Neurobiology of Aging, Vol. 30, Núm. 6, pp. 973-986

  2. Dopamine transporter glycosylation correlates with the vulnerability of midbrain dopaminergic cells in Parkinson's disease

    Neurobiology of Disease, Vol. 36, Núm. 3, pp. 494-508

2005

  1. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection

    Current Neurovascular Research, Vol. 2, Núm. 4, pp. 287-301